These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 9307197

  • 1. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie.
    Mertens R, Granzen B, Lassay L, Gademann G, Hess CF, Heimann G.
    Cancer; 1997 Sep 01; 80(5):951-9. PubMed ID: 9307197
    [Abstract] [Full Text] [Related]

  • 2. Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH).
    Mertens R, Granzen B, Lassay L, Bucsky P, Hundgen M, Stetter G, Heimann G, Weiss C, Hess CF, Gademann G.
    Cancer; 2005 Sep 01; 104(5):1083-9. PubMed ID: 15999363
    [Abstract] [Full Text] [Related]

  • 3. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.
    Rodriguez-Galindo C, Wofford M, Castleberry RP, Swanson GP, London WB, Fontanesi J, Pappo AS, Douglass EC.
    Cancer; 2005 Feb 15; 103(4):850-7. PubMed ID: 15641027
    [Abstract] [Full Text] [Related]

  • 4. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT, Sham JS, Au GK.
    Head Neck; 2004 Feb 15; 26(2):118-26. PubMed ID: 14762880
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 15; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 6. Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy.
    Zubizarreta PA, D'Antonio G, Raslawski E, Gallo G, Preciado MV, Casak SJ, Scopinaro M, Morales G, Sackmann-Muriel F.
    Cancer; 2000 Aug 01; 89(3):690-5. PubMed ID: 10931470
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
    Fonseca E, Cruz JJ, Rodríguez CA, Gómez-Bernal A, Martín G, Sánchez P, Nieto A, Soria P, Vega MJ, Muñoz A, Pardal JL.
    J Infus Chemother; 1996 Aug 01; 6(4):217-20. PubMed ID: 9229319
    [Abstract] [Full Text] [Related]

  • 8. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH, Wu HG, Heo DS, Kim KH, Sung MW, Park CI.
    Laryngoscope; 2008 Apr 01; 118(4):663-70. PubMed ID: 18216741
    [Abstract] [Full Text] [Related]

  • 9. Nasopharyngeal carcinoma in childhood and adolescence: a single institution's experience with treatment modalities during the last 15 years.
    Polychronopoulou S, Kostaridou S, Panagiotou JP, Stefanaki K, Papadakis V, Florentin L, Houlakis M, Christopoulos G, Haidas S.
    Pediatr Hematol Oncol; 2004 Apr 01; 21(5):393-402. PubMed ID: 15205082
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M, Sanguineti G, D'Amico M, Corvò R, Ricci I, Numico G, Guarneri D, Vitale V, Pallestrini E, Santelli A, Rosso R.
    Br J Cancer; 2000 Dec 01; 83(11):1437-42. PubMed ID: 11076650
    [Abstract] [Full Text] [Related]

  • 11. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A, Vigo V, Marcenaro M, Bacigalupo A, Gatteschi B, Ravetti JL, Corvò R, Benasso M.
    Oral Oncol; 2008 Aug 01; 44(8):767-74. PubMed ID: 18061519
    [Abstract] [Full Text] [Related]

  • 12. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
    Lin JC, Jan JS, Chen KY, Hsu CY, Liang WM, Wang WY.
    Head Neck; 2003 Jun 01; 25(6):438-50. PubMed ID: 12784235
    [Abstract] [Full Text] [Related]

  • 13. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT, Sham JS, Choy D, Lorvidhaya V, Sumitsawan Y, Thongprasert S, Vootiprux V, Cheirsilpa A, Azhar T, Reksodiputro AH.
    Cancer; 1998 Dec 01; 83(11):2270-83. PubMed ID: 9840526
    [Abstract] [Full Text] [Related]

  • 14. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
    Maoleekoonpairoj S, Phromratanapongse P, Puttanuparp S.
    J Med Assoc Thai; 1997 Dec 01; 80(12):778-84. PubMed ID: 9470331
    [Abstract] [Full Text] [Related]

  • 15. Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.
    Lin JC, Jan JS, Hsu CY, Jiang RS, Wang WY.
    Br J Cancer; 2003 Jan 27; 88(2):187-94. PubMed ID: 12610501
    [Abstract] [Full Text] [Related]

  • 16. High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood.
    Nakamura RA, Novaes PE, Antoneli CB, Fogaroli RC, Pellizzon AC, Ferrigno R, Maia MA, Salvajoli JV, Pereira AJ, Nishimoto IN.
    Cancer; 2005 Aug 01; 104(3):525-31. PubMed ID: 15986481
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
    Al-Amro A, Al-Rajhi N, Khafaga Y, Memon M, Al-Hebshi A, El-Enbabi A, El-Husseiny G, Radawi A, Belal A, Allam A, El-Sebaie M.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):508-13. PubMed ID: 15890594
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
    Baghi M, Hambek M, May A, Radeloff A, Gstoettner W, Knecht R.
    Anticancer Res; 2006 Jun 01; 26(1B):559-63. PubMed ID: 16739320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.